Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
  1. 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $2.88 ($143,984)
  2. 4 Open-market buy CEO & Chairman bought 150,000 shares at an average $2.98 ($446,794)
  3. 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $3.00 ($599,316)
  4. 4/A Grant or award Director acquired 312,612 shares (grant or award)
  5. 4 Open-market buy CEO & Chairman bought 400,000 shares at $2.83 ($1,132,400)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Vice Chairman and President bought 89,600 shares at $2.79 ($250,396)
  9. 4 Grant or award Director acquired 312,612 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy CEO & Chairman bought 400,000 shares at $2.78 ($1,113,560)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy CEO & Chairman bought 35,000 shares at an average $3.04 ($106,317)
  15. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.13 ($312,865)
  16. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.11 ($310,796)
  17. 4 Open-market buy CEO & Chairman bought 750,000 shares at $3.09 ($2,315,325)
  18. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.04 ($303,569)
  19. 4 Open-market buy CEO & Chairman bought 150,000 shares at an average $3.03 ($455,009)
  20. 4 Open-market buy CEO & Chairman bought 350,000 shares at an average $2.98 ($1,041,817)

Page 9 of 106 · 2,118 filings